Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Lars Fruergaard Jørgensen
CEOLars Fruergaard Jørgensen
Employees
63,370
Employees63,370
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1931
Founded1931
Employees
63,370
Employees63,370

NVO Key Statistics

Market cap
384.85B
Market cap384.85B
Price-Earnings ratio
27.91
Price-Earnings ratio27.91
Dividend yield
1.19%
Dividend yield1.19%
Average volume
6.72M
Average volume6.72M
High today
$87.97
High today$87.97
Low today
$85.84
Low today$85.84
Open price
$87.12
Open price$87.12
Volume
6.77M
Volume6.77M
52 Week high
$148.15
52 Week high$148.15
52 Week low
$81.50
52 Week low$81.50

NVO News

TipRanks 3d
Novo Nordisk price target lowered to DKK 900 from DKK 1,000 at Deutsche Bank

Deutsche Bank analyst Emmanuel Papadakis lowered the firm’s price target on Novo Nordisk (NVO) to DKK 900 from DKK 1,000 and keeps a Buy rating on the shares....

Quartz 4d
Trump’s play for Greenland could make Ozempic more expensive

Denmark is the latest in a series of countries that President-elect Donald Trump has threatened with tariffs — joining a list that includes the 26 other nations...

Trump’s play for Greenland could make Ozempic more expensive
Seeking Alpha 4d
Novo, Eli Lilly to dominate global pharma sales in 2025: report

Blockbuster weight loss medications from Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) lead Evaluate Pharma’s list of best-selling drugs projected for 2025 after...

Novo, Eli Lilly to dominate global pharma sales in 2025: report

Analyst ratings

71%

of 31 ratings
Buy
71%
Hold
19.4%
Sell
9.7%

More NVO News

CNBC 5d
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Medicare drug plans can now cover Eli Lilly 's bloc...

Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Benzinga 5d
Novo Nordisk Seeks to Strengthen Obesity Pipeline With Two Back-To-Back Biobuck Deals

On Wednesday, Novo Nordisk A/S NVO and Valo Health, Inc. entered into an expanded agreement to discover and develop novel treatments for obesity, type 2 diabete...

Novo Nordisk Seeks to Strengthen Obesity Pipeline With Two Back-To-Back Biobuck Deals
The Motley Fool 5d
This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly

Eli Lilly (LLY 0.83%) and Novo Nordisk (NVO 2.22%) are two of the most valuable healthcare stocks in the world, largely due to their successful diabetes and wei...

This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly
Barron's 5d
Novo Nordisk Faces 5 Key Questions, Says Analyst

Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of America addresses the company’s earn...

Novo Nordisk Faces 5 Key Questions, Says Analyst
Seeking Alpha 5d
Novo Nordisk, Valo Health expand drug discovery deal

Danish drugmaker Novo Nordisk (NVO) (OTCPK:NONOF) and AI-focused biotech Valo Health announced Wednesday an agreement to expand their existing collaboration to...

Novo Nordisk, Valo Health expand drug discovery deal
MarketWatch 5d
Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact - MarketWatch

...

Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact - MarketWatch
Barron's 6d
Trump’s Denmark Tariff Threat Means New Uncertainty for Ozempic Drugmaker Novo Nordisk

It’s not at all clear what a tariff would mean for Novo, which manufactures its medicines in facilities all over the world, including in the U.S. View comments...

Trump’s Denmark Tariff Threat Means New Uncertainty for Ozempic Drugmaker Novo Nordisk
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.